"10.1371_journal.pone.0106748","plos one","2014-09-12T00:00:00Z","Xavier Sol√©; Marta Crous-Bou; David Cordero; David Olivares; Elisabet Guin√≥; Rebeca Sanz-Pamplona; Francisco Rodriguez-Moranta; Xavier Sanjuan; Javier de Oca; Ramon Salazar; Victor Moreno","Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO) and CIBERESP, Hospitalet de Llobregat, Barcelona, Spain; Colorectal Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain; Department of Gastroenterology, University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain; Department of Pathology, University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain; Department of General and Digestive Surgery, Colorectal Unit, University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain","Conceived and designed the experiments: XS MCB DC VM. Performed the experiments: DO MCB. Analyzed the data: XS MCB DC EG VM. Contributed reagents/materials/analysis tools: XS MCB DC DO VM. Contributed to the writing of the manuscript: XS MCB DC EG RSP VM. Recruitment of patients and collection of clinical data: FRM XSJ JDO RS.","The authors have filed a patent regarding the use of COL10A1 as biomarker for early diagnosis of colon cancer with title: ‚ÄúSERUM BIOMARKER FOR DIAGNOSING COLORECTAL CANCER‚Äù. European patent number: EP2680003A1 (28.06.2012) and Spain ES2436667A2(03.01.2014). The authors confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials.","2014","09","Xavier Sol√©","XS√",11,TRUE,4,2,5,NA,TRUE,TRUE,FALSE,0,NA,FALSE
